Product Name :
Prifuroline
Description:
Prifuroline is an antiarrhythmic agent.
CAS:
70833-07-7
Molecular Weight:
228.29
Formula:
C14H16N2O
Chemical Name:
3-(1-benzofuran-2-yl)-N,N-dimethyl-3,4-dihydro-2H-pyrrol-5-amine
Smiles :
CN(C)C1CC(CN=1)C1=CC2=CC=CC=C2O1
InChiKey:
IYMLHOSZPZHXCR-UHFFFAOYSA-N
InChi :
InChI=1S/C14H16N2O/c1-16(2)14-8-11(9-15-14)13-7-10-5-3-4-6-12(10)17-13/h3-7,11H,8-9H2,1-2H3
Purity:
≥98% (or refer to the Certificate of Analysis)
Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition :
Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.{{Upadacitinib} MedChemExpress|{Upadacitinib} Epigenetics|{Upadacitinib} Purity & Documentation|{Upadacitinib} Purity|{Upadacitinib} custom synthesis|{Upadacitinib} Autophagy}
Shelf Life:
≥12 months if stored properly.{{ME-344} web|{ME-344} Metabolic Enzyme/Protease|{ME-344} Protocol|{ME-344} Description|{ME-344} supplier|{ME-344} Autophagy}
Stock Solution Storage:
0 – 4 oC for 1 month or refer to the Certificate of Analysis.PMID:23907521
Additional information:
Prifuroline is an antiarrhythmic agent.|Product information|CAS Number: 70833-07-7|Molecular Weight: 228.29|Formula: C14H16N2O|Chemical Name: 3-(1-benzofuran-2-yl)-N,N-dimethyl-3,4-dihydro-2H-pyrrol-5-amine|Smiles: CN(C)C1CC(CN=1)C1=CC2=CC=CC=C2O1|InChiKey: IYMLHOSZPZHXCR-UHFFFAOYSA-N|InChi: InChI=1S/C14H16N2O/c1-16(2)14-8-11(9-15-14)13-7-10-5-3-4-6-12(10)17-13/h3-7,11H,8-9H2,1-2H3|Technical Data|Appearance: Solid Power|Purity: ≥98% (or refer to the Certificate of Analysis)|Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis|Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.|Shelf Life: ≥12 months if stored properly.|Stock Solution Storage: 0 – 4 oC for 1 month or refer to the Certificate of Analysis.|Drug Formulation: To be determined|HS Tariff Code: 382200|How to use|In Vivo:|Prifuroline is an antiarrhythmic agent. Prifuroline dose-dependently antagonizes the arrhythmogenic action of aconitine in rats, when administered either intravenously (5, 10 or 20 mg/kg) or intraduodenally (10, 20 or 50 mg/kg). Prifuroline also diminishes ventricular susceptibility to electrical stimulation in open-chest rats. The arrhythmias induced in dogs by coronary artery ligation are markedly antagonized by Prifuroline after doses of 5 and 10 mg/kg i.v. or 30 mg/kg intraduodenally. The duration of its antiarrhythmic activity in this model of arrhythmias in conscious dogs is much longer after intraduodenal than after i.v. administration.|Products are for research use only. Not for human use.|